Beloy, Alvien M.
HRN: 16-92-00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/27/2023
CO-AMOXICLAV 625MG (TAB)
09/27/2023
10/04/2023
PO
625mg
BID
Multiple STI, Laceration
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes